Read articles from Global

December 04, 2024 by filtermag.org

Difference in Vapers’ Respiratory Symptoms Vs. Non-Vapers Is Minimal

A new study focused on the impact of vaping on non-smokers found minimal respiratory symptoms among participants who vape but do not smoke. Published in Scientific Reports, the research challenges previous assumptions linking vaping to smoking-related harms. Led by CoEHAR researchers at the University of Catania, Italy, the study involved a diverse group of adults across six regions. Despite a slight increase in respiratory symptoms among vapers, the difference was not clinically significant. The study underscores the importance of balanced discussions on vaping's risks and benefits, advocating for further research to inform policies.

December 03, 2024 by regulatorwatch.com

Pressure Test | U.S. Vape Industry Argues Case at Supreme Court

Today, the U.S. vaping industry finally had its day before the United States Supreme Court. Eric Heyer, the attorney representing Triton Distribution and Vapetasia, argued that the U.S. Food and Drug Administration moved the goalposts in its evaluation of nicotine vaping products under the agency’s PMTA process. In this episode of RegWatch, we bring you key moments from today’s landmark Supreme Court session and critical reactions from vape industry attorney Greg Troutman and Jim McCarthy of the American Vapor Manufacturers Association. Is the Supreme Court ready to back vaping?

December 03, 2024 by euronews.com

Health ministers buck Parliament to green-light stronger tobacco restrictions

EU health ministers have endorsed new recommendations from the European Commission to tighten restrictions on tobacco and aerosol products, despite the European Parliament rejecting the same proposal last week. The initiative seeks to address health risks by extending existing smoking bans to outdoor areas and covering novel products like nicotine-free vapes. Health Commissioner Olivér Várhelyi, speaking at his first Council meeting, highlighted that tobacco consumption causes 700,000 preventable deaths annually in the EU. He emphasized that no level of second-hand smoke exposure is safe, referencing the World Health Organization.

December 03, 2024 by washingtonpost.com

Supreme Court appears sympathetic to FDA’s rejection of flavored vapes

The Supreme Court considered FDA's rejection of flavored e-cigarette applications appealing to youngsters. E-cigarettes, seen as less harmful but still risky, face scrutiny due to youth vaping popularity. Concerns include nicotine addiction impacting brain development and respiratory issues. The FDA's standards for product approvals were questioned in the hearing. The case, revolving around the 2009 Tobacco Control Act, highlights the tension between aiding adult smokers and preventing youth uptake. Despite a decline in youth e-cigarette use, flavored liquids' appeal remains contested, with health risks debated. Industry pushback against FDA denials continues. The Supreme Court case raises issues of youth health protection and regulatory clarity.

December 03, 2024 by washingtonpost.com

Supreme Court appears sympathetic to FDA’s rejection of flavored vapes

The Supreme Court considered FDA's rejection of flavored e-cigarette applications appealing to youngsters. E-cigarettes, seen as less harmful but still risky, face scrutiny due to youth vaping popularity. Concerns include nicotine addiction impacting brain development and respiratory issues. The FDA's standards for product approvals were questioned in the hearing. The case, revolving around the 2009 Tobacco Control Act, highlights the tension between aiding adult smokers and preventing youth uptake. Despite a decline in youth e-cigarette use, flavored liquids' appeal remains contested, with health risks debated. Industry pushback against FDA denials continues. The Supreme Court case raises issues of youth health protection and regulatory clarity.

December 03, 2024 by biomedcentral.com

People who use drugs and the right to health - Harm Reduction Journal

The text discusses the right to health for individuals who use drugs, covering aspects like access to healthcare, social determinants of health, and meaningful participation. It highlights international conventions, obligations of Member States, and the importance of addressing social, economic, legal, and cultural factors impacting health outcomes. The paper emphasizes the need for evidence-based drug treatment and reducing stigma in healthcare. It also stresses the significance of empowering affected communities in health policy decisions. Furthermore, it points out the challenges faced by people who use drugs in participating in policy dialogue and the implications of criminalization on their right to meaningful participation in healthcare decisions.

December 02, 2024 by npr.org

FDA battles vaping industry at the Supreme Court

The U.S. Supreme Court tackles vaping regulations concerning e-cigarettes, particularly their appeal to teenagers. E-cigarettes have replaced traditional tobacco products but are now popular among youth, prompting concerns about addiction. The FDA's evolving guidelines on flavors and marketing of vaping products face scrutiny in court battles. Challenges to FDA decisions highlight inconsistencies in regulations. The outcome could impact the availability of flavored e-cigarettes to minors. The case reflects a broader debate on balancing public health goals against industry practices.

December 02, 2024 by usatoday.com

Teen vaping hits a decade-low. Could Supreme Court review of flavored vapes reverse this?

Teen vaping is at a decade-low due to federal regulations on flavored vapes. The Supreme Court will review if the FDA's block on flavored e-cigarettes was fair. E-cigarettes are popular among youth despite health risks. The industry argues FDA regulations were unreasonable. Trump expressed support for flavored vapes in the past. The Court's decision could impact the industry and public health efforts. FDA regulations may affect the approval of new vaping products. The outcome will be crucial for the e-cigarette industry and public health advocates.

December 02, 2024 by gfn.tv

GFN Insights #2 | HARM REDUCTION IN ACTION | Featuring Adriana Curado

Harm reduction specialist Adriana Curado joins us in this episode of #GFNInsights to highlight how frontline harm reduction interventions have positively impacted marginalised communities in Portugal.

December 02, 2024 by theconversation.com

How big tobacco firms are using e-cigarettes to try to improve their image

The tobacco industry, worth £730 billion annually, is evolving with e-cigarettes to broaden its appeal. Despite claims of commitment to health improvement, tobacco companies use manipulative messaging. They emphasize consumer choice and downplay their role in addiction. The rise of e-cigarettes, linked to misleading health promises, is concerning, especially among youth. Tobacco firms' narrative shift promotes confusion and obstructs public health policies. Clever renaming and lobbying add to the misinformation. Despite global suffering, big tobacco resists stricter regulations.

RELATED VIDEOS

video youtube thumbnail

28 September 2026

76% of the Global Vape Market Is Illicit?!

video youtube thumbnail

19 November 2026

CRITICAL MASS | Global Safer Nicotine Use Reaches 200 Million

video youtube thumbnail

10 July 2026

Europe’s New Prohibition: The End of Safer Nicotine? | Dr Konstantinos Farsalinos

video youtube thumbnail

24 August 2026

Nicotine Pouches in Scandinavia - How Sales Have Changed From 2018 to 2025?

video youtube thumbnail

23 August 2024

What are the key insights from Global Forum on Nicotine? | #GFNVoices24

video youtube thumbnail

13 May 2026

THR Global - The Building Block Secret to Changing Tobacco Policy

video youtube thumbnail

27 May 2024

What makes GFN24 a truly GLOBAL event?

video youtube thumbnail

22 December 2025

Global Forum on Nicotine 2025 Closing remarks by David Sweanor